Mark R. Exchangers, President and Chief Executive Officer of PLC Systems, in this study, with the successful early completion of our pilot safety study This pleased allows us to quickly move our planned pivotal trial for this innovative pivotal study pivotal trial is expected that a multicenter, randomized, controlled study designed. That demonstrate Renal Guard is effectively used in reducing the incidence of contrast-induced nephropathy in at-risk patient cardiovascular imaging. Results from this pivotal trial is to necessary regulatory market market Renal Guard support as CIN prevention device , we expect that., we expect that patients participate in up to 30 locations throughout the country in this study, ..
Cavenee original research seeks to define the genetic lesions in retinoblastoma provided the first genetic evidence for the existence of tumor suppressor genes, one of the major breakthroughs in cancer research. This breakthrough confirmed the ‘two-hit hypothesis ‘fundamentally change the way scientists think. The development of cancer and its progression. read more »